US Patent 11492408 Bi-specific T-cell engager specific for BCMA
Patent 11492408 was granted and assigned to UCL Business Ltd on November, 2022 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 11492408 Bi-specific T-cell engager specific for BCMA
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
